Estradiol 50 mcg / norethindrone acetate 250 mcg/Day Twice Weekly Transdermal System
RxNorm 1251499
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1251499 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: estradiol 50 mcg / norethindrone acetate 250 mcg/Day Twice Weekly Transdermal System.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
84 HR estradiol 0.00208 mg/HR / norethindrone acetate 0.0104 mg/HR Transdermal System
(Atom ID: 12344554)
SYPrescribable
Synonym (SY):
Estradiol 0.00208 mg / norethindrone acetate 0.0104 mg per HR 84 HR Transdermal Patch
(Atom ID: 4261816)
SYPrescribable
Synonym (SY):
Estradiol 0.05 mg / norethindrone acetate 0.25 mg per Day Twice Weekly Transdermal Patch
(Atom ID: 5030152)
PSNPrescribable
Prescribable Name (PSN):
Estradiol 50 mcg / norethindrone acetate 250 mcg/Day Twice Weekly Transdermal System
(Atom ID: 8246285)
PTPrescribable
Designated preferred name (PT):
Estradiol 50 microgram/24 hour and norethindrone acetate 250 microgram/24 hour prolonged-release transdermal patch
(Atom ID: 13028743)
SYPrescribable
Synonym (SY):
Estradiol 50 microgram/24 hour and norethisterone acetate 250 microgram/24 hour prolonged-release transdermal patch
(Atom ID: 13028746)
FNPrescribable